Rapid and sensitive liquid chromatographic method for determination of paclitaxel from parenteral formulation and nanoparticles

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 4, 2010, Pages 465-470

  Kollipara, S ^a   Bende, G ^a   Saha, R N ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

nanoparticles; paclitaxel; parenteral formulation; RP HPLC

Indexed keywords

NANOPARTICLE; PACLITAXEL; PARENTERAL SOLUTION;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS;

EID: 78650524682     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.73914     Document Type: Article

References (15)

1. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995;332:1004-14.
2. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 1990:82; 1247-59.
3. Nakajima M, Fujiki Y, Kyo S, Kanaya T, Nakamura M, Maida Y, et al. Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1. J Clin Pharmacol 2005;45:674-82. (Pubitemid 40696210)
4. Friedland D, Gorman G, Treat J. Hypersensitivity reactions from taxol and etoposide. J Natl Cancer Inst 1993;85:2036. (Pubitemid 24000989)
5. Kim SC, YU J, Lee JW, Park ES, Chi SC. Sensitive HPLC method for quantitation of paclitaxel (Genexol®) in biological samples with application to preclinical pharmacokinetics and biodistribution. J Pharm Biomed Anal 2005;39:170-6. (Pubitemid 41112134)
6. Panchagnula R, Babu DA, Kaur KJ, Singh I, Kaul CL. Determination of paclitaxel in human plasma by HPLC. Pharm Pharmacol Commun 1999;5:587-9. (Pubitemid 29524930)
7. Caporossi L, Rosa MD, Pera A, Papaleo B. Simple analytical method for the determination of paclitaxel (Taxol®) levels in human plasma. Chromatographia 2007;66:921-4. (Pubitemid 350211967)
8. Suno M, Ono T, Iida S, Umetsu N, Ohtaki K, Yamada T, et al. Improved high-performance liquid chromatographic detection of paclitaxel in patient's plasma using solid-phase extraction, and semimicro- bore C18 separation and UV detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007;860:141-4. (Pubitemid 350161472)
9. Badea I, Ciutaru D, Lazar L, Nicolescu D, Tudose A. Rapid HPLC method for the determination of paclitaxel in pharmaceutical forms without separation. J Pharm Biomed Anal 2004;34:501-7. (Pubitemid 38177339)
10. Anupama M, Deepak C, Neeraj K. HPLC method for the determination of carboplatin and paclitaxel with cremophorEL in an amphiphilic polymer matrix. J Chromatogr B Analyt Technol Biomed Life Sci 2007;855:211-9.
11. Guerrero DQ, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998;24:1113-28. (Pubitemid 28546092)
12. The Eurpoean Agency for the Evaluation of Medical Products. ICH Topic Q2B: Note for Guidance on Validation of Analytical Procedures: Methodology GPMP/ICH/281/95, 1996.
13. Bolton S. Pharmaceutical statistics: practical and clinical applications. New York: Marcel Dekker; 1997.
14. Levy MY, Benita S. Drug release from submicronized o/w emulsion: A new in vitro kinetic evaluation model. Int J Pharm 1990;66:29-37.
15. Barzegar-Jalali M, Adibkia K, Valizadeh H, Shadbad MR, Nokhodchi A, Omidi Y, et al. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci 2008;11:167-77.